- Home
- BNC vs PRTA Comparison
BNC vs PRTA Comparison
Compare BNC & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNC
- PRTA
- Stock Information
- Founded
- BNC N/A
- PRTA 2012
- Country
- BNC United States
- PRTA Ireland
- Employees
- BNC N/A
- PRTA N/A
- Industry
- BNC Industrial Machinery/Components
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- BNC Industrials
- PRTA Health Care
- Exchange
- BNC Nasdaq
- PRTA Nasdaq
- Market Cap
- BNC 406.7M
- PRTA 472.1M
- IPO Year
- BNC N/A
- PRTA N/A
- Fundamental
- Price
- BNC $7.70
- PRTA $9.90
- Analyst Decision
- BNC
- PRTA Buy
- Analyst Count
- BNC 0
- PRTA 9
- Target Price
- BNC N/A
- PRTA $13.14
- AVG Volume (30 Days)
- BNC 1.5M
- PRTA 668.8K
- Earning Date
- BNC 11-13-2025
- PRTA 11-11-2025
- Dividend Yield
- BNC N/A
- PRTA N/A
- EPS Growth
- BNC N/A
- PRTA N/A
- EPS
- BNC N/A
- PRTA N/A
- Revenue
- BNC $4,027,431.00
- PRTA $10,341,000.00
- Revenue This Year
- BNC N/A
- PRTA N/A
- Revenue Next Year
- BNC N/A
- PRTA $602.32
- P/E Ratio
- BNC N/A
- PRTA N/A
- Revenue Growth
- BNC 27.46
- PRTA N/A
- 52 Week Low
- BNC $5.60
- PRTA $4.32
- 52 Week High
- BNC $82.88
- PRTA $18.88
- Technical
- Relative Strength Index (RSI)
- BNC 35.34
- PRTA 53.43
- Support Level
- BNC $6.96
- PRTA $9.61
- Resistance Level
- BNC $8.49
- PRTA $10.61
- Average True Range (ATR)
- BNC 0.99
- PRTA 0.46
- MACD
- BNC 0.31
- PRTA -0.12
- Stochastic Oscillator
- BNC 14.17
- PRTA 20.93
About BNC CEA Industries Inc. Common Stock
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.